B. Levy, O. Bastien, and K. Bendjelid, Experts' recommendations for the management of adult patients with cardiogenic shock, Ann Intensive Care, vol.5, p.52, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01206314

P. Ponikowski, A. A. Voors, and S. D. Anker, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, vol.37, pp.2129-2200, 2016.

H. R. Reynolds and J. S. Hochman, Cardiogenic shock: current concepts and improving outcomes, Circulation, vol.117, pp.686-697, 2008.

N. Aissaoui, E. Puymirat, and X. Tabone, Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries, Eur Heart J, vol.33, pp.2535-2543, 2002.

A. Reyentovich, M. H. Barghash, and J. S. Hochman, Management of refractory cardiogenic shock, Nat Rev Cardiol, vol.13, pp.481-492, 2016.

J. S. Hochman, Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm, Circulation, vol.107, pp.2998-3002, 2003.

R. J. Goldberg, F. A. Spencer, J. M. Gore, D. Lessard, and J. Yarzebski, Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective, Circulation, vol.119, pp.1211-1219, 2009.

H. Thiele, B. Allam, G. Chatellier, G. Schuler, and A. Lafont, Shock in acute myocardial infarction: the Cape Horn for trials?, Eur Heart J, vol.31, pp.1828-1835, 2010.

R. V. Jeger, D. Radovanovic, and P. R. Hunziker, Ten-year trends in the incidence and treatment of cardiogenic shock, Ann Intern Med, vol.149, pp.618-626, 2008.

E. Puymirat, J. Y. Fagon, and P. Aegerter, Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, Eur J Heart Fail, vol.19, pp.192-200, 1997.

V. Kunadian, W. Qiu, and P. Ludman, Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society), JACC Cardiovasc Interv, vol.7, pp.1374-1385, 2014.

A. Mebazaa, A. Combes, and S. V. Diepen, Management of cardiogenic shock complicating myocardial infarction, Intensive Care Med, vol.44, issue.6, pp.760-773, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01871224

M. Schmidt, A. Burrell, and L. Roberts, Predicting survival after ECMO for refractory cardiogenic shock: the survival after venoarterial-ECMO (SAVE)-score, Eur Heart J, vol.36, pp.2246-2256, 2015.

M. Shah, S. Patnaik, and B. Patel, Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States, Clin Res Cardiol, vol.107, pp.287-303, 2017.

N. Aissaoui, E. Puymirat, and T. Simon, Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute STelevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry, Crit Care, vol.18, p.516, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01313020

J. S. Hochman, L. A. Sleeper, J. G. Webb, T. A. Sanborn, H. D. White et al., Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock, N Engl J Med, vol.341, pp.625-634, 1999.

J. S. Hochman, L. A. Sleeper, and J. G. Webb, Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction, JAMA, vol.295, issue.21, pp.2511-2515, 2006.

F. Neumann, M. Sousa-uva, and A. Ahlsson, ESC/EACTS Guidelines on myocardial revascularization, European Heart Journal, vol.40, issue.2, pp.87-165, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02393795

S. C. Wong, T. Sanborn, and L. A. Sleeper, Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?, J Am Coll Cardiol, vol.36, 2000.

M. Saad, G. Fuernau, and S. Desch, Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial, EuroIntervention, vol.14, pp.306-319, 2018.

L. P. Hoebers, M. M. Vis, and B. E. Claessen, The impact of multivessel disease with and without a coexisting chronic total occlusion on short-and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock, Eur J Heart Fail, vol.15, pp.425-457, 2013.

B. Ibanez, S. James, and S. Agewall, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, European Heart Journal, vol.39, issue.2, pp.119-77, 2017.

H. Thiele, I. Akin, and M. Sandri, PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock, New England Journal of Medicine, vol.377, issue.25, pp.2419-2451, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01891555

C. M. O'connor, W. A. Gattis, and B. F. Uretsky, Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST), Am Heart J, vol.138, pp.78-86, 1999.

D. M. Ouweneel and J. P. Henriques, Percutaneous Cardiac Support Devices for Cardiogenic Shock: current indications and recommendations, Heart, vol.98, issue.16, pp.1246-54, 2012.

V. P. Harjola, W. Mullens, and M. Banaszewski, Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the, European Society of Cardiology

, Eur J Heart Fail, vol.19, pp.821-836, 2017.

R. Prondzinsky, H. Lemm, and M. Swyter, Intraaortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome, Crit Care Med, vol.38, pp.152-160, 2009.

H. Thiele, U. Zeymer, and F. J. Neumann, Intraaortic balloon support for myocardial infarction with cardiogenic shock, N Engl J Med, vol.367, pp.1287-1296, 2012.

Y. Ahmad, S. Sen, and M. J. Shun-shin, Intra-aortic balloon pump therapy for acute myocardial infarction: a metaanalysis, JAMA Intern Med, vol.175, pp.931-939, 2015.

D. Kawashima, S. Gojo, and T. Nishimura, Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation, ASAIO J, vol.57, pp.169-176, 2011.

J. E. Bavaria, M. B. Ratcliffe, K. B. Gupta, R. K. Wenger, D. K. Bogen et al., Changes in left ventricular systolic wall stress during biventricular circulatory assistance, Ann Thorac Surg, vol.45, pp.526-532, 1998.

S. Waha, G. Fuernau, and S. Desch, Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort, EuroIntervention, vol.12, pp.412-413, 2016.

A. Ouattara, A. Remy, and A. Quessard, Extracorporeal life support for refractory cardiogenic shock: "an efficient system support of peripheral more than real ventricular assist device?, Anaesth Crit Care Pain Med, vol.37, pp.195-196, 2018.

S. Aso, H. Matsui, K. Fushimi, and H. Yasunaga, The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database, Crit Care Med, vol.44, pp.1974-1979, 2016.

F. Pappalardo, C. Schulte, and M. Pieri, Concomitant implantation of Impella® on top of venoarterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock, Eur J Heart Fail, vol.19, pp.404-412, 2017.

A. Combes, P. Leprince, and C. E. Luyt, Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock, Crit Care Med, vol.36, issue.5, pp.1404-1411, 2008.

R. Cheng, R. Hachamovitch, and M. Kittleson, Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients, Ann Thorac Surg, vol.97, pp.610-616, 2014.

S. Beurtheret, P. Mordant, and X. Paoletti, Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program), Eur Heart J, vol.34, issue.2, pp.112-132, 2013.

G. Muller, E. Flecher, and G. Lebreton, The ENCOURAGE mortality risk score and analysis of longterm outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock, Intensive Care Med, vol.42, pp.370-378, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01274303

H. Kim, S. H. Lim, and J. Hong, Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock, Resuscitation, vol.83, pp.971-975, 2012.

N. W. Tsao, C. M. Shih, and J. S. Yeh, Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock, J Crit Care, vol.27, issue.530, pp.1-11, 2012.

S. Sattler, N. Khaladj, and M. M. Zaruba, Extracorporal life support (ECLS) in acute ischaemic cardiogenic shock, int J Clin Pract, vol.68, pp.529-531, 2014.

L. D. Sauren, R. E. Accord, and K. Hamzeh, Combined Impella® and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study, Artif Organs, vol.31, pp.839-842, 2007.

D. Burkhoff, G. Sayer, D. Doshi, and N. Uriel, Hemodynamics of mechanical circulatory support, J Am Coll Cardiol, vol.66, pp.2663-2674, 2015.

S. Watanabe, K. Fish, and J. C. Kovacic, Left ventricular unloading using an Impella® CP improves coronary flow and infarct zone perfusion in ischemic heart failure, J Am Heart Assoc, vol.6, pp.117-135, 2018.

N. Uriel, G. Sayer, S. Annamalai, N. K. Kapur, and D. Burkhoff, Mechanical unloading in heart failure, J Am Coll Cardiol, vol.72, pp.569-580, 2018.

N. K. Kapur, Y. Qiao, and V. Paruchuri, Mechanical preconditioning with acute circulatory support before reperfusion limits infarct size in acute myocardial infarction, JACC Heart Fail, vol.3, pp.873-882, 2015.

N. K. Kapur, M. Alkhouli, and T. Demartini, Unloading the left ventricle before reperfusion in patients with anterior st-segment elevation myocardial infarction: a pilot study using the Impella CP®, Circulation, vol.139, pp.337-346, 2019.

F. Casassus, J. Corre, and L. Leroux, The use of Impella® 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction, J Interv Cardiol, vol.28, pp.41-50, 2015.

C. Mastroianni, N. Bouabdallaoui, P. Leprince, and G. Lebreton, Short-term mechanical circulatory support with the Impella® 5.0 device for cardiogenic shock at La Pitié-Salpêtrière, Eur Heart J Acute Cardiovasc Care, vol.6, pp.87-92, 2017.

A. Myat, N. Patel, S. Tehrani, A. P. Banning, S. R. Redwood et al., Percutaneous circulatory assist devices for highrisk coronary intervention, JACC Cardiovasc Interv, vol.8, pp.229-273, 2015.

S. R. Dixon, J. P. Henriques, and L. Mauri, A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience, JACC Cardiovasc Interv, vol.2, pp.91-97, 2009.

W. O'neill, N. S. Kleiman, and J. Moses, A prospective, randomized clinical trial of hemodynamic support with Impella® 2.5 versus intraaortic balloon pump in patients undergoing high-risk percutaneous coronary intervention The PROTECT II Study, Circulation, vol.126, pp.1717-1727, 2012.

G. D. Dangas, A. S. Kini, and S. K. Sharma, Impact of hemodynamic support with Impella® 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing highrisk percutaneous coronary intervention (from the PROTECT II Randomized Trial), Am J Cardiol, vol.113, pp.222-228, 2014.

J. C. Kovacic, A. Kini, and S. Banerjee, Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial, J Interv Cardiol, vol.28, pp.32-40, 2015.

M. B. Basir, T. L. Schreiber, and C. L. Grines, Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock, Am J Cardiol, vol.119, pp.845-851, 2017.

W. W. O'neill, T. Schreiber, and D. H. Wohns, The current use of Impella® 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry, J Interv Cardiol, vol.27, pp.1-11, 2013.

M. P. Flaherty, K. R. Khan, O. Neil, and W. W. , Early initiation of Impella® in acute myocardial infarction complicated by cardiogenic shock improves survival, JACC Cardiovasc Interv, vol.10, pp.1805-1806, 2017.

A. E. Engstrom, R. Cocchieri, and A. H. Driessen, The Impella® 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience, Crit Care Med, vol.39, pp.2072-2079, 2011.

M. Lindholm, M. Hongisto, and J. Lassus, Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients with Cardiogenic Shock -Results from The Cardshock Study, Shock, vol.28, pp.41-50, 2019.

P. Jensen, S. Kann, and K. Veien, Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock, Eur Heart J, vol.7, issue.1, pp.53-61, 2018.

D. M. Ouweneel, J. De-brabander, and M. Karami, Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience, Eur Heart J, vol.8, issue.4, pp.338-349, 2019.

C. L. Rohm, B. Gadidov, M. Leitson, H. E. Ray, and R. Prasad, Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device, Am J Cardiol, vol.124, issue.4, pp.499-504, 2019.

V. P. Harjola, J. Lassus, and A. Sionis, Clinical picture and risk prediction of short-term mortality in cardiogenic shock, Eur J Heart Fail, vol.17, issue.5, pp.501-510, 2015.

D. C. Raja, A. Chopra, and V. Subban, Predictors of short-term outcomes in patients undergoing percutaneous coronary intervention in cardiogenic shock complicating STEMI-A tertiary care center experience, Indian Heart J, vol.70, issue.3, pp.259-264, 2018.

S. Akin, D. Miranda, D. Caliskan, and K. , Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock, Crit Care, vol.21, issue.1, p.265, 2017.

R. J. Van-der-schaaf, B. E. Claessen, and M. M. Vis, Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock, Am J Cardiol, vol.105, pp.955-959, 2010.

B. E. Claessen, G. D. Dangas, and G. Weisz, Prognostic impact of a chronic total occlusion in a noninfarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial, Eur Heart J, vol.33, pp.768-775, 2012.

H. Watanabe, T. Morimoto, and H. Shiomi, Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock

, Catheter Cardiovasc Interv, vol.92, issue.3, pp.455-463, 2018.

P. W. Serruys, Y. Onuma, and S. Garg, Assessment of the SYNTAX score in the syntax study, EuroIntervention, vol.5, pp.50-56, 2009.

P. W. Serruys, M. C. Morice, and A. P. Kappetein, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, vol.360, pp.961-972, 2009.

S. Garg, G. Sarno, and P. W. Serruys, Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, JACC Cardiovasc Interv, vol.4, pp.66-75, 2011.

T. Palmerini, P. Genereux, and A. Caixeta, Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Analysis from the ACUITY (acute catheterization and urgent intervention triage StrategY) trial, J Am Coll Cardiol, vol.57, pp.2389-2397, 2011.

M. Magro, S. Nauta, and C. Simsek, Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAX score study, Am Heart J, vol.161, pp.771-781, 2011.

T. Onuk, B. Gungor, and G. Ipek, Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease, Coron Artery Dis, vol.27, pp.311-318, 2016.

T. Javanainen, J. Sans-roselló, V. Harjola, M. S. Nieminen, J. Lassus et al., Prognostic impact of baseline and residual SYNTAX scores in cardiogenic shock, Catheter Cardiovasc Interv. 1 janv, vol.93, issue.1, pp.1-8, 2019.

J. P. Henriques, L. P. Hoebers, and T. Ramunddal, Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: The EXPLORE trial, J Am Coll Cardiol, vol.68, pp.1622-1632, 2016.

. Engstrømt, H. Kelbaek, and S. Helqvist, Complete revascularization versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): An open-label, randomised controlled trial, Lancet, vol.386, pp.665-671, 2015.

D. S. Wald, J. K. Morris, and N. J. Wald, Randomized trial of preventive angioplasty in myocardial infarction, N Engl J Med, vol.369, pp.1115-1123, 2013.

S. R. Mehta, D. A. Wood, R. F. Storey, R. Mehran, K. R. Bainey et al., Complete Revascularization with Multivessel PCI for Myocardial Infarction, N Engl J Med, 2019.

P. C. Smits, M. Abdel-wahab, and F. J. Neumann, Compare-Acute Investigators. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction, N Engl J Med, vol.376, pp.1234-1244, 2017.

A. H. Gershlick, J. N. Khan, and D. J. Kelly, Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT trial, J Am Coll Cardiol, vol.65, pp.963-972, 2015.

J. M. Lee, T. M. Rhee, and J. Y. Hahn, Multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction with cardiogenic shock, J Am Coll Cardiol, vol.71, pp.844-856, 2018.